Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Low Dose Pioglitazone Compared with Standard Dose Pioglitazone in Type 2 Diabetes with Chronic Kidney Disease
TCTR20180424002Phase 4Completed
- Sponsor
- Phramongkutklao Hospital and College of Medicine
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), sponsored by Phramongkutklao Hospital and College of Medicine. Started Jan 2014; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20180424002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180424002.